未登录

B

Bing Han

Shanghai Jiaotong University School of Medicine

H指数:21

被引数:1,883

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Population-based screening of CYP17A1 Y329fs mutation carriers in the Han Chinese population

汉族人群CYP17A1 Y329fs突变携带者的基于人群的筛查

Genes & Diseases

IF9.4

2025-04-150

OAAI

Clinical spectrum and molecular basis in 19 Chinese patients with 46, XY disorder of sexual development caused by NR5A1 mutations

ORPHANET JOURNAL OF RARE DISEASES

IF3.5

2024-12-020

OAAI

Gene signature developed based on programmed cell death to predict the therapeutic response and prognosis for liver hepatocellular carcinoma

基于程序性细胞死亡开发的基因签名，以预测肝肝细胞癌的治疗反应和预后

IF3.6

2024-07-010

OAAI

Deficiency of the HGF/Met pathway leads to thyroid dysgenesis by impeding late thyroid expansion

NATURE COMMUNICATIONS

IF15.7

2024-04-110

OAAI

In-frame deletion of SMC5 related with the phenotype of primordial dwarfism, chromosomal instability and insulin resistance

SMC5的框内缺失与原始侏儒症表型，染色体不稳定性和胰岛素抵抗有关

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2023-01-107

OAAI

Natural Killer Cells in Hepatic Ischemia-Reperfusion Injury

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-03-2823

OAAI

Phenotypic Heterogeneity and Fertility Potential of Patients With 17-Hydroxylase/17,20-lyase Deficiency

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2022-01-1912

OA

Differences of adrenal-derived androgens in 5α-reductase deficiency versus androgen insensitivity syndrome

肾上腺源性雄激素在5 α-还原酶缺乏症与雄激素不敏感综合征中的差异

CTS-CLINICAL AND TRANSLATIONAL SCIENCE

IF2.8

2021-11-117

OA

Upregulation of GBP1 in thyroid primordium is required for developmental thyroid morphogenesis

GENETICS IN MEDICINE

IF6.2

2021-10-0116

OAAI

Molecular and clinical genetics of the transcription factor GLIS3 in Chinese congenital hypothyroidism

MOLECULAR AND CELLULAR ENDOCRINOLOGY

IF3.6

2021-05-014

PREAI

Phenotypic and biochemical characteristics and molecular basis in 36 Chinese patients with androgen receptor variants

ORPHANET JOURNAL OF RARE DISEASES

IF3.5

2021-03-093

OAAI

Exome sequencing identifies somatic mutations in novel driver genes in non-small cell lung cancer

IF3.9

2020-07-0610

OAAI

Inherited Missense Mutation Occurring in Arginine76 of the SRY Gene Does Not Account for Familial 46, XY Sex Reversal

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2020-03-063

OA

Bioinformatic Analysis Identifies Potential Key Genes in the Pathogenesis of Turner Syndrome

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2020-03-0634

OAAI

Assessment of Molecular Subtypes in Thyrotoxic Periodic Paralysis and Graves Disease Among Chinese Han Adults A Population-Based Genome-Wide Association Study

JAMA NETWORK OPEN

IF9.7

2019-05-0315

OAAI

Zhao, Shuang-Xia; Liu, Wei; Liang, Jun; Gao, Guan-Qi; Zhang, Xiao-Mei; Yao, Yu; Wang, Hai-Ning; Yuan, Fei-Fei; Xue, Li-Qiong; Ma, Yu-Ru; Zhang, Le-Le; Ye, Xiao-Ping; Zhang, Qian-Yue; Sun, Feng; Zhang, Rui-Jia; Yang, Shao-Ying; Zhan, Ming; Du, Wen-Hua; Liu, Bing-Li; Chen, Xia; Song, Zhi-Yi; Li, Xue-Song; Li, Ping; Ru, Ying; Zuo, Chun-Lin; Li, Sheng-Xian; Han, Bing; Zhu, Hui; Qiao, Jie; Xuan, Miao; Su, Bin; Sun, Fei; Ma, Jun-Hua; Chen, Jia-Lun; Tian, Hao-Ming; Chen, Sai-Juan; Song, Huai-Dong; Pan, Chun-Ming; Yuan, Guo-Yue; Li, Chang-Gui; Chen, Jia-Lun; Liu, Li-Bin; Chen, Gang; Su, Qing; Peng, Yong-De; Zhao, Jia-Jun

Next-generation sequencing reveals genetic landscape in 46, XY disorders of sexual development patients with variable phenotypes

IF3.6

2018-03-2660

PREAI

Polymorphism in the Alternative Donor Site of the Cryptic Exon of LHCGR: Functional Consequences and Associations with Testosterone Level

SCIENTIFIC REPORTS

IF3.9

2017-04-0314

OAAI

A POU3F4 Mutation Causes Nonsyndromic Hearing Loss in a Chinese X-linked Recessive Family

POU3F4突变导致中国X连锁隐性家庭的非综合征性听力损失

CHINESE MEDICAL JOURNAL

IF7.3

2017-01-0511

OAAI

Aromatase deficiency: a novel compound heterozygous mutation identified in a Chinese girl with severe phenotype and obvious maternal virilization

MOLECULAR AND CELLULAR ENDOCRINOLOGY

IF3.6

2016-09-0119

PREAI

Clinical and molecular manifestation of fifteen 17OHD patients: a novel mutation and a founder effect

IF2.9

2016-05-0521

PREAI